AAAAAA
Results:
1-7
|
Results: 7
Authors:
WEBB MS
LOGAN P
KANTER PM
STONGE G
GELMON K
HARASYM T
MAYER LD
BALLY MB
Citation: Ms. Webb et al., PRECLINICAL PHARMACOLOGY, TOXICOLOGY AND EFFICACY OF SPHINGOMYELIN CHOLESTEROL LIPOSOMAL VINCRISTINE FOR THERAPEUTIC TREATMENT OF CANCER/, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 461-470
Authors:
KANTER PM
OTWELL JA
Citation: Pm. Kanter et Ja. Otwell, DIABETES CASE-MANAGEMENT - EXPLORING STAFF PRACTICE PATTERNS, The Diabetes educator, 22(4), 1996, pp. 333
Authors:
KANTER PM
KING JM
BALLY MB
MAYER LD
Citation: Pm. Kanter et al., LIPOSOME-ENCAPSULATED VINCRISTINE - PRECLINICAL TOXICOLOGIC AND PHARMACOLOGICAL COMPARISON WITH FREE VINCRISTINE AND EMPTY LIPOSOMES IN MICE, RATS AND DOGS - REPLY, Anti-cancer drugs, 6(2), 1995, pp. 329-330
Authors:
KLAICH GM
KANTER PM
Citation: Gm. Klaich et Pm. Kanter, CHARACTERIZATION OF A MONOCLONAL-ANTIBODY RECOGNIZING A 138-KDA GLIOBLASTOMA-ASSOCIATED ANTIGEN, Anti-cancer drugs, 6(1), 1995, pp. 45-52
Authors:
KANTER PM
KLAICH GM
BULLARD GA
KING JM
BALLY MB
MAYER LD
Citation: Pm. Kanter et al., LIPOSOME-ENCAPSULATED VINCRISTINE - PRECLINICAL TOXICOLOGIC AND PHARMACOLOGICAL COMPARISON WITH FREE VINCRISTINE AND EMPTY LIPOSOMES IN MICE, RATS AND DOGS, Anti-cancer drugs, 5(5), 1994, pp. 579-590
Authors:
KANTER PM
BULLARD GA
KING JM
Citation: Pm. Kanter et al., PRECLINICAL TOXICOLOGIC EVALUATION OF DENSPM (N1, N-11-DIETHYLNORSPERMINE) IN RATS AND DOGS, Anti-cancer drugs, 5(4), 1994, pp. 448-456
Authors:
KLAICH GM
KANTER PM
Citation: Gm. Klaich et Pm. Kanter, INDUCTION OF DOG IL-1 BY FREE AND LIPOSOMAL ENCAPSULATED DOXORUBICIN, Anti-cancer drugs, 5(3), 1994, pp. 355-360
Risultati:
1-7
|